View on market: Stay Cautious, be with quality business:

U.S. stocks retreated ahead of Wednesday’s inflation report to gauge the path of Federal Reserve tightening. The S&P 500 dropped for a fourth consecutive session, while the Nasdaq 100 underperformed. Treasury yields climbed, while the dollar fell. As of 6:15 am, the Singapore-traded SGX Nifty–an early barometer of India’s benchmark Nifty 50–was 0.14% lower at 17,516.5 points. Equities fell in Japan, South Korea and Australia. Oil reversed an earlier decline as Russian shipments via the southern leg of a major pipeline to Europe were suspended. Brent futures rose as much as 1.6% to trade near $98 a barrel, after earlier dropping 1.8%. On Monday, the Indian benchmarks had got off to a volatile start but ended the day with clear gains. The S&P BSE Sensex gained 0.8% to 58,853.07, while NSE Nifty 50 Index gained a similar magnitude to end at 17525.1.

Economic Calendar:

  • USD : Core CPI (MoM) (Jul) 10th Aug, 2022
  • USD : CPI (YoY) (Jul) 10th Aug, 2022
  • INR : M3 Money Supply 10th Aug, 2022
  • INR : CPI (YoY) (Jul) 12th Aug, 2022

Q1FY23 Result Today: Coal India, Eicher Motors, Hindalco Industries, Tata Consumer Products, IRCTC, Aarti Industries, Abbott India, Arvind Fashions, Ashoka Buildcon, CESC, Cochin Shipyard, Cummins India, Endurance Technologies, General Insurance Corporation of India, Glenmark Pharmaceuticals, Indiabulls Housing Finance, Ipca Laboratories, Indian Railway Finance Corporation

Q1FY23 Result:

Bharti Airtel Q1 FY23 (Consolidated, YoY) posted over a five-fold jump in its consolidated profit to ₹1,607 crore, mainly on account of hike in tariffs. The company had posted a profit of ₹283.5 crore in the same period a year ago. Consolidated revenue from operations of increased by about 22% to ₹32,805 crore during the reported quarter from ₹26,854 crore earlier.

Tata Chemicals Q1 FY23 (Consolidated, YoY) reported an 86.25% increase in consolidated net profit at ₹637 crore during the quarter ending June. The company’s net profit stood at ₹342 crore in the corresponding quarter of the previous fiscal. Revenue from operations went up by 34.15% during the quarter under review at ₹3,995 crore compared to ₹2,978 crore in the same period of last fiscal.

JK Tyre Q1 FY23 (Consolidated, YoY) posted 39% YoY increase in revenue to ₹3,650 crore in the first quarter of the current financial year. EBIDTA for the first quarter of 2022-23 stood at ₹291 crore. The company’s PBT stood at ₹57 crore for the quarter.

Brokerage Radar:

NOMURA ON ABB: Maintain NEUTRAL, TP Rs 2268; Significant EBITDA Margin, Strong Order Inflows; Strong Sales growth beats estimates; Sluggish industrial capex and commodity price rises are downside risks

JPM ON INDIAN HOTELS: Maintain Overweight, TP Rs315; Q1 beats on all counts and provides a preview of what an upcycle could look like; Revise FY23-25 Profit estimate by 23%, see 3.5% Revenue over FY23-26

JEFFERIES ON BHARTI AIRTEL: Maintains Buy, TP 704, Revenue EBITDA largely in-line with estimates; ARPU roses 3% QoQ, Further rise will require tariff hikes; Tweak FY23-25 Revenue/EBITDA Estimates by up to 1%; lower profit estimates by 4-12% to factor in Q1 results

International Markets:

U.S & Europe:

Particulars      09th August Chg. Chg.(%)
Nasdaq 12493.93 -150.53 -1.19
Dow 327774.41 -58.13 -0.18
FTSE 7488.15 5.78 0.08
CAC 6490.00 -34.44 -0.53
DAX 13534.97 -152.72 -1.12
Dow Fut.* 32779.6 5.20 0.02

Asian markets:

Particulars      09th August Chg. Chg.(%)
SGX Nifty 17531 -9.50 -0.05
Nikkei 27767.07 -232.89 -0.83
Straits Times 3283.91 12.93 0.40
Hang Seng 19583.66 -419.78 -2.1
Shanghai 3230.69 -16.74 -0.52

ADR Watch:

Particulars       09th August Chg. Chg.(%)
Dr. Reddy 52.91 -0.26 -0.49
HDFC Bank 63.07 0 0
ICICI Bank 21.31 0.04 0.19
Infosys 20.18 -0.09 -0.44
Tata Motor 29.54 -0.05 -0.17
Wipro 5.37 -0.06 -1.10

Commodities & Currency:

Particulars Current Price Chg.(%)
USD/INR 79.66 0.54
Brent 96.03  -0.29
Gold 1809.45 -0.16
Silver 20.453 -0.14

FIIs & DIIs:

Particulars 08th August 05th August
FIIs                           1449.70  1605.81
DIIs  -140.73    -495.94

News Update:

Strides Pharma: has a target to launch 20 products every year in the U.S. market and has a growth outlook of $250 million in FY23 for the U.S. business.

AU Small Finance Bank: approved issue price for QIP at Rs 580 per share (including a premium of Rs. 570 per share) which is at a discount of 1.83% to the floor price.

Spandana Sphoorty: The Reserve Bank of India imposed a penalty of Rs 2.33 crore for failure to adhere to pricing of credit guidelines for NBFCs.

HFCL: entered into an agreement with Qualcomm Technologies for the design and development of 5G millimetre wave fixed wireless access products for broadband services.

Source: Moneyontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL